TY - JOUR
T1 - Botulinum toxin as a novel treatment for chronic exertional compartment syndrome in the U.S. military
AU - Hutto, Wesley M.
AU - Schroeder, Paul B.
AU - Leggit, Jeffery C.
N1 - Publisher Copyright:
© Association of Military Surgeons of the United States 2018.
PY - 2019/5/1
Y1 - 2019/5/1
N2 - Chronic exertional compartment syndrome (CECS) is a debilitating condition that is not uncommon in athletes and military service members. The only curative treatment for this condition, surgical fascial release, was first described in 1956. In the ensuing 62 years, this has remained the standard therapy despite symptom recurrence in 45% of military service members who underwent surgery. In 2013, a case series introduced intracompartmental injections of botulinum toxin A as a non-surgical treatment option for CECS, which proved effective in 15 out of 16 patients. In this case report, we present the case of a U.S. military service member treated with BoNT-A for bilateral lower leg CECS. This patient remains pain free at 11 months after initial treatment. This case, coupled with previously published cases series, demonstrates the potential of this novel treatment as a long-term, non-surgical alternative for CECS in the U.S. military population.
AB - Chronic exertional compartment syndrome (CECS) is a debilitating condition that is not uncommon in athletes and military service members. The only curative treatment for this condition, surgical fascial release, was first described in 1956. In the ensuing 62 years, this has remained the standard therapy despite symptom recurrence in 45% of military service members who underwent surgery. In 2013, a case series introduced intracompartmental injections of botulinum toxin A as a non-surgical treatment option for CECS, which proved effective in 15 out of 16 patients. In this case report, we present the case of a U.S. military service member treated with BoNT-A for bilateral lower leg CECS. This patient remains pain free at 11 months after initial treatment. This case, coupled with previously published cases series, demonstrates the potential of this novel treatment as a long-term, non-surgical alternative for CECS in the U.S. military population.
UR - http://www.scopus.com/inward/record.url?scp=85066258954&partnerID=8YFLogxK
U2 - 10.1093/milmed/usy223
DO - 10.1093/milmed/usy223
M3 - Article
C2 - 30215765
AN - SCOPUS:85066258954
SN - 0026-4075
VL - 184
SP - e458-e461
JO - Military Medicine
JF - Military Medicine
IS - 5-6
M1 - usy223
ER -